VOSE, JULIE M.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a necessary component

Jamil Y. Abuzetun, Fausto Loberiza, Julie Vose, Philip Bierman, R. Greg Bociek, Charles Enke, Martin Bast, Dennis Weisenburger, James O. Armitage, for the Nebraska Lymphoma Study Group

Journal:

British Journal of Haematology

Year:

2009

Language:

english

File:

PDF, 264 KB

english, 2009

2

Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation

Julie M. Vose, James O. Armitage, Philip J. Bierman, Dennis D. Weisenburger, Mark Hutchins, Monroe D. Dowling, Daniel F. Moravec, Scot Sorensen, John Okerbloom, George Bascom, David Howe, P. Steven Jo

Journal:

The American Journal of Medicine

Year:

1989

Language:

english

File:

PDF, 502 KB

english, 1989

3

Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphoma

Corey M. Munger, Ganapati V. Hegde, Dennis D. Weisenburger, Julie M. Vose, Shantaram S. Joshi

Journal:

Cancer Immunology, Immunotherapy

Year:

2012

Language:

english

File:

PDF, 1.01 MB

english, 2012

4

Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma

Herrera, Alex F., Moskowitz, Alison J., Bartlett, Nancy L., Vose, Julie M., Ramchandren, Radhakrishnan, Feldman, Tatyana A., LaCasce, Ann S., Ansell, Stephen M., Moskowitz, Craig H., Fenton, Keenan, O

Journal:

Year:

2017

Language:

english

File:

PDF, 677 KB

english, 2017

5

Recent Advances in CAR-T Cell Therapy for Non-Hodgkin Lymphoma

Kallam, Avyakta, Vose, Julie M.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

Language:

english

File:

PDF, 257 KB

english, 2019

6

Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group

Dennis D. Weisenburger, Julie M. Vose, Timothy C. Greiner, James C. Lynch, Wing C. Chan, Philip J. Bierman, Bhavana J. Dave, Warren G. Sanger, James O. Armitage

Journal:

American Journal of Hematology

Year:

2000

Language:

english

File:

PDF, 222 KB

english, 2000

7

Histologic grade does not predict prognosis in optimally treated, advanced-stage nodular sclerosing Hodgkin's disease

Aneal S. Masih, Dennis D. Weisenburger, Julie M. Vose, Martin A. Bast, James O. Armitage

Journal:

Year:

1992

Language:

english

File:

PDF, 500 KB

english, 1992

8

Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies

Julie M. Vose, Barbara C. Kennedy, Philip J. Bierman, Anne Kessinger, James O. Armitage

Journal:

Year:

1992

Language:

english

File:

PDF, 586 KB

english, 1992

9

Peripheral T-cell lymphoma in childhood and adolescence a clinicopathologic study of 22 patients

Bruce G. Gordon, Dennis D. Weisenburger, Phyllis I. Warkentin, James Anderson, Warren G. Sanger, Martin Bast, David Gnarra, Julie M. Vose, Phillip J. Bierman, James O. Armitage, Peter F. Coccia

Journal:

Year:

1993

Language:

english

File:

PDF, 688 KB

english, 1993

10

Prognostic significance of clinical and pathologic features in diffuse large B-cell lymphoma

Hirokazu Nakamine, Dennis D. Weisenburger, Robert G. Bagin, Julie M. Vose, Martin A. Bast, Philip J. Bierman, James O. Armitage

Journal:

Year:

1993

Language:

english

File:

PDF, 685 KB

english, 1993

11

Prognostic factors influencing survival in patients with B-cell small lymphocytic lymphoma

Marin Nola, Steven Z. Pavletic, Dennis D. Weisenburger, Lynette M. Smith, Martin A. Bast, Julie M. Vose, James O. Armitage

Journal:

American Journal of Hematology

Year:

2004

Language:

english

File:

PDF, 107 KB

english, 2004

12

Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation

Steven Z. Pavletic, Lynette M. Smith, Michael R. Bishop, James C. Lynch, Stefano R. Tarantolo, Julie M. Vose, Philip J. Bierman, Abdul Hadi, James O. Armitage, Anne Kessinger

Journal:

American Journal of Hematology

Year:

2005

Language:

english

File:

PDF, 119 KB

english, 2005

13

Non-Hodgkin lymphoma of the prostate

John Steuter, Dennis D. Weisenburger, R. Greg Bociek, Philip Bierman, Julie Vose, Martin Bast, Fausto Loberiza, James O. Armitage

Journal:

American Journal of Hematology

Year:

2011

Language:

english

File:

PDF, 324 KB

english, 2011

14

Sarcoidosis mimicking recurrent lymphoma

Wei Li, Karen Holdeman, Javier A. Laurini, Philip J. Bierman, Julie M. Vose, Robert Gregory Bociek, James O. Armitage

Journal:

American Journal of Hematology

Year:

2012

Language:

english

File:

PDF, 133 KB

english, 2012

15

Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphoma

Richard R. Furman, Peter Martin, Jia Ruan, Ying-Kuen K. Cheung, Julie M. Vose, Ann S. LaCasce, Rebecca Elstrom, Morton Coleman, John P. Leonard

Journal:

Year:

2010

Language:

english

File:

PDF, 169 KB

english, 2010

16

Personalized immunotherapy for the treatment of non-Hodgkin's lymphoma: a promising approach

Journal:

Hematological Oncology

Year:

2006

Language:

english

File:

PDF, 174 KB

english, 2006

17

Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome

Ekaterina Chigrinova, Michael Mian, Marta Scandurra, Timothy C. Greiner, Wing C. Chan, Julie M. Vose, Giorgio Inghirami, Annalisa Chiappella, Luca Baldini, Maurilio Ponzoni, Andrés J.M. Ferreri, Silvi

Journal:

Hematological Oncology

Year:

2011

Language:

english

File:

PDF, 382 KB

english, 2011

18

Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin’s lymphoma or Hodgkin’s lymphoma

Francis J Giles, Julie M Vose, Kim-Anh Do, Marcella M Johnson, Taghi Manshouri, Gregory Bociek, Philip J Bierman, Susan M O’Brien, Hagop M Kantarjian, James O Armitage, Maher Albitar

Journal:

Leukemia Research

Year:

2004

Language:

english

File:

PDF, 102 KB

english, 2004

19

Clinical relevance of soluble HLA-I and β2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease

Maher Albitar, Julie M. Vose, Marcella M. Johnson, Kim-Ann Do, Amanda Day, Iman Jilani, Hagop Kantarjian, Michael Keating, Susan M. O’Brien, Srdan Verstovsek, James O. Armitage, Francis J. Giles

Journal:

Leukemia Research

Year:

2007

Language:

english

File:

PDF, 480 KB

english, 2007

20

Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries

Elisabeth Vandenberghe, Carmen Ruiz de Elvira, Fausto R. Loberiza, E Conde, A. López-Guillermo, C. Gisselbrecht, F. Guilhot, Julie M. Vose, Koen van Biesen, J. Douglas Rizzo, Dennis D. Weisenburger, P

Journal:

British Journal of Haematology

Year:

2003

Language:

english

File:

PDF, 153 KB

english, 2003

21

Circulating CD20 and CD52 in patients with non-Hodgkin's lymphoma or Hodgkin's disease

Francis J. Giles, Julie M. Vose, Kim-Anh Do, Marcella M. Johnson, Taghi Manshouri, Gregory Bociek, Philip J. Bierman, Susan M. O'Brien, Michael J. Keating, Hagop M Kantarjian, James O. Armitage, Maher

Journal:

British Journal of Haematology

Year:

2003

Language:

english

File:

PDF, 317 KB

english, 2003

22

High dose chemotherapy and autologous transplantation for non-Hodgkin’s lymphoma

Journal:

International Journal of Hematology

Year:

2002

Language:

english

File:

PDF, 389 KB

english, 2002

23

Hematopoietic stem cell transplantation for Hodgkin’s disease in a patient with dysfibrinogenemia and thrombosis

Apar Kishor Ganti, Julie M. Vose, William D. Haire

Journal:

Journal of Thrombosis and Thrombolysis

Year:

2007

Language:

english

File:

PDF, 121 KB

english, 2007

24

Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project

Charles L. Bennett, Andrew M. Evens, Leslie A. Andritsos, Lakshmi Balasubramanian, Mark Mai, Matthew J. Fisher, Timothy M. Kuzel, Cara Angelotta, June M. McKoy, Julie M. Vose, Philip J. Bierman, Davi

Journal:

British Journal of Haematology

Year:

2006

Language:

english

File:

PDF, 94 KB

english, 2006

25

Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma

Thomas M. Habermann, Izidore S. Lossos, Glen Justice, Julie M. Vose, Peter H. Wiernik, Kyle McBride, Kenton Wride, Annette Ervin-Haynes, Kenichi Takeshita, Dennis Pietronigro, Jerome B. Zeldis, Joseph

Journal:

British Journal of Haematology

Year:

2009

Language:

english

File:

PDF, 154 KB

english, 2009

26

Late relapse in patients with diffuse large B-cell lymphoma

Julie M. Vose, Dennis D. Weisenburger, Fausto R. Loberiza, Alejandro Arevalo, Martin Bast, Joel Armitage, Philip J. Bierman, Robert G. Bociek, James O. Armitage

Journal:

British Journal of Haematology

Year:

2010

Language:

english

File:

PDF, 194 KB

english, 2010

27

Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21

Marta Scandurra, Michael Mian, Timothy C. Greiner, Paola M. V. Rancoita, Cassio P. De Campos, Wing C. Chan, Julie M. Vose, Ekaterina Chigrinova, Giorgio Inghirami, Annalisa Chiappella, Luca Baldini, M

Journal:

British Journal of Haematology

Year:

2010

Language:

english

File:

PDF, 469 KB

english, 2010

28

Integrated profiling of diffuse large B-cell lymphoma with 7q gain

Ekaterina Chigrinova, Michael Mian, Yulei Shen, Timothy C. Greiner, Wing C. Chan, Julie M. Vose, Giorgio Inghirami, Annalisa Chiappella, Luca Baldini, Maurilio Ponzoni, Andrés J. M. Ferreri, Silvia Fr

Journal:

British Journal of Haematology

Year:

2011

Language:

english

File:

PDF, 122 KB

english, 2011

29

Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP

Monica Testoni, Ivo Kwee, Timothy C. Greiner, Santiago Montes-Moreno, Julie Vose, Wing C. Chan, Annalisa Chiappella, Luca Baldini, Andrés J.M. Ferreri, Gianluca Gaidano, Michael Mian, Emanuele Zucca,

Journal:

British Journal of Haematology

Year:

2011

Language:

english

File:

PDF, 166 KB

english, 2011

30

The differential effect of lenalidomide monotherapy in patients with relapsed or refractory transformed non-Hodgkin lymphoma of distinct histological origin

Myron S. Czuczman, Julie M. Vose, Thomas E. Witzig, Pier L. Zinzani, Rena Buckstein, Jonathan Polikoff, Ju Li, Dennis Pietronigro, Annetti Ervin-Haynes, Craig B. Reeder

Journal:

British Journal of Haematology

Year:

2011

Language:

english

File:

PDF, 109 KB

english, 2011

31

Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management

Journal:

American Journal of Hematology

Year:

2012

Language:

english

File:

PDF, 217 KB

english, 2012

32

A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma

Bruce D. Cheson, Nancy L. Bartlett, Julie M. Vose, Andres Lopez-Hernandez, Amanda L. Seiz, Anne T. Keating, Setareh Shamsili

Journal:

Year:

2012

Language:

english

File:

PDF, 232 KB

english, 2012

33

Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantation

Keni Gu, Dennis D Weisenburger, Kai Fu, Wing C Chan, Timothy C Greiner, Patricia Aoun, Lynette M Smith, Martin Bast, Zhongfen Liu, R. Gregory Bociek, Philip J Bierman, James O Armitage, Julie M Vose

Journal:

Hematological Oncology

Year:

2012

Language:

english

File:

PDF, 310 KB

english, 2012

34

Novel therapy for therapy-resistant mantle cell lymphoma: Multipronged approach with targeting of hedgehog signaling

Ganapati V. Hegde, Tara M. Nordgren, Corey M. Munger, Amit K. Mittal, Philip J. Bierman, Dennis D. Weisenburger, Julie M. Vose, J. Graham Sharp, Shantaram S. Joshi

Journal:

International Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 1.13 MB

english, 2012

35

High dose cyclophosphamide, etoposide and carmustine and peripheral stem cell transplantation for patients with relapsed hodgkin disease and bone marrow abnormalities

Anne Kessinger, Julie M. Vose, Philip J. Bierman, James O. Armitage

Journal:

Year:

1992

Language:

english

File:

PDF, 134 KB

english, 1992

36

Granulocyte-macrophage colony-stimulating factor as adjunct therapy in relapsed lymphoid malignancy: Implications for economic analyses of phase III clinical trials

Charles L. Bennett, Stephen L. George, James O. Armitage, Julie M. Vose, John J. Nemunaitis, Jack L. Armitage, N. Claude Gorin, Subhash C. Gulati

Journal:

Year:

1995

Language:

english

File:

PDF, 560 KB

english, 1995

37

Clinical outcome of peripheral blood stem cell support

Anne Kessinger, James Armitage, Philip Bierman, Michael Bishop, Shantaram Joshi, Elizabeth Reed, Graham Sharp, James Talmadge, Julie Vose

Journal:

Medical Oncology

Year:

1994

Language:

english

File:

PDF, 335 KB

english, 1994

38

Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion

Avadhut D. Joshi, John D. Dickinson, Ganapati V. Hegde, Warren G. Sanger, James O. Armitage, Philip J. Bierman, Robert G. Bociek, Marcel P. Devetten, Julie M. Vose, Shantaram S. Joshi

Journal:

Cancer Genetics and Cytogenetics

Year:

2007

Language:

english

File:

PDF, 194 KB

english, 2007

39

Dendritic Cell-based Therapy for Mantle Cell Lymphoma

Corey Munger, Ganapati Hegde, Julie Vose, Shantaram Joshi, Dennis Weisenburger

Journal:

Clinical Immunology

Year:

2007

Language:

english

File:

PDF, 41 KB

english, 2007

40

Targeting Conic Hedgehog-GLI Signaling for the Treatment of Mantle Cell Lymphoma

Ganapati Hegde, Corey Munger, Katy Emanuel, Dennis Weisenburger, Avadhut Joshi, Julie Vose, Shantaram Joshi

Journal:

Clinical Immunology

Year:

2007

Language:

english

File:

PDF, 41 KB

english, 2007

41

412-O. Core Trauma Nursing in the Emergency Department: Improving the Care of the Trauma Patient

Marie C. Dieter, Julie Albertson, Cheryl Lansenderfer, Rosemary Scheirer, Laurie Cartwright, Courtney Vose

Journal:

Journal of Emergency Nursing

Year:

2006

Language:

english

File:

PDF, 43 KB

english, 2006

42

Establishing an institutional model for the administration of tositumomab and iodine I 131 tositumomab

Maribeth A. Hohenstein, Samuel C. Augustine, Frank Rutar, Julie M. Vose

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 401 KB

english, 2003

43

Immune dysfunction despite high levels of immunoregulatory cytokine gene expression in autologous peripheral blood stem cell transplanted non-Hodgkin's lymphoma patients

Rakesh K. Singh, Michelle L. Varney, Kazuhiko Ino, Julie M. Vose, Philip J. Bierman, James E. Talmadge

Journal:

Experimental Hematology

Year:

2000

Language:

english

File:

PDF, 289 KB

english, 2000

44

Early-Stage Hodgkin Disease in a 24-Year-Old Woman

Christopher Peters, Eli Glatstein, Julie Vose, Lisa C. Thomas, Gloria J. Morris

Journal:

Seminars in Oncology

Year:

2011

Language:

english

File:

PDF, 1.69 MB

english, 2011

45

Anthracycline-containing chemotherapy improves survival for over 60 year olds with aggressive non-Hodgkin lymphoma

Journal:

Evidence-based Oncology

Year:

2002

Language:

english

File:

PDF, 76 KB

english, 2002

46

The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma

Zdravko Mitrovic, Martin Bast, Philip J. Bierman, Robert G. Bociek, Julie M. Vose, Wing C. Chan, James O. Armitage

Journal:

British Journal of Haematology

Year:

2012

Language:

english

File:

PDF, 101 KB

english, 2012

47

A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphoma

Jonathan L. Kaufman, Christopher R. Flowers, Karen D. Rados, Gary B. Calandra, Julie M. Vose, L. Becker Hewes, Sagar Lonial, Amelia A. Langston, H. Jean Khoury, Mary Jo Lechowicz, Edmund K. Waller

Journal:

Transfusion (Wiley)

Year:

2012

Language:

english

File:

PDF, 144 KB

english, 2012

48

Improving Outcomes for Patients with Diffuse Large B-cell Lymphoma

Christopher R. Flowers, Rajni Sinha, Julie M. Vose

Journal:

CA: A Cancer Journal for Clinicians

Year:

2010

Language:

english

File:

PDF, 197 KB

english, 2010

49

Recurrent streptococcus mutans endocarditis

Julie M. Vose, Philip W. Smith, Marietta Henry, David Colan

Journal:

The American Journal of Medicine

Year:

1987

Language:

english

File:

PDF, 310 KB

english, 1987

50

Autologous bone marrow transplantation for patients with relapsed hodgkin's disease

James O. Armitage, Philip J. Bierman, Julie M. Vose, James R. Anderson, Dennis D. Weisenburger, Anne Kessinger, Elizabeth C. Reed, William P. Vaughan, Peter F. Coccia, David T. Purtilo

Journal:

The American Journal of Medicine

Year:

1991

Language:

english

File:

PDF, 835 KB

english, 1991